Get notified when GOVX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Going Concern (new) — The company's auditors have expressed substantial doubt about its ability to continue as a going concern.
- Warrant Dilution (new) — Outstanding warrants for about 3.9 million shares at a weighted average exercise price of $5.70, with 2.8 million having anti-dilution provisions that will lower the exercise price upon this offering, increasing potential dilution.
GeoVax Labs prices $1.0M offering of 402,000 shares at $2.31 plus pre-funded warrants
Filed February 17, 2026 · ~2 min read
Key Changes
-
high
GeoVax is selling 402,000 shares at $2.31 and 30,902 pre-funded warrants at $2.30999, for gross proceeds of about $1.0 million.
The Offering verify on EDGAR → -
high
After placement agent fees and expenses, the company expects net proceeds of approximately $865,000.
Use of Proceeds verify on EDGAR → -
medium
Net proceeds will fund product candidates, including research, manufacturing, clinical studies, and working capital, with broad management discretion.
Use of Proceeds verify on EDGAR →
3 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (MU 10-K) is open in full — no account needed.
Partner
Trade GOVX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify